Successfully conducted E&Y cGMP audit in May 2018.    2D barcode printing on all products implemented from May 2018.   Received ISO 9001:2015 Certification in July 2018.   Received ISO 14001:2015 Certification in December 2019.   Received ISO 45001:2018 Certification in December 2020.

Xorbact® 500mg IM/IV

Sulbactam sodium/cefoperazone sodium combination is available as a dry powder for reconstitution in 1:1 in terms of free SBT/CPZ. Sulbactam sodium is a derivative of the basic penicillin nucleus. It is an irreversible beta-lactamase inhibitor for parenteral use only

Xorbact 500 MG

  • Dosage and Administration

    Daily dosage recommendations for sulbactam/cefoperazone in adults are as follows:

    Ratio SBT/CPZ (g) Sulbactam Activity (g) Cefoperazone Activity (g)
    1:1 2.0 _ 4.0 1.0 _ 2.0 1.0 _ 2.0

    Doses should be administered every 12 hours in equally divided doses. In severe or refractory infections, the daily dosage of cefoperazone/sulbactam may be increased up to 8g of the 1:1 ratio (i.e. 4g Cefoperazone activity), patients receiving the 1:1 ratio may require additional cefoperazone administered separately. Doses should be administered every 12 hours in equally divided doses. The recommended maximum daily dosage of sulbactam is 4g.

Product Leaflet

Xorbact-Insert